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Abstract  
 
Experimental autoimmune encephalomyelitis (EAE) was induced in Lewis rats by the i.v. injection of 
107 cloned Vβ8.2+ T cells specific for the 72-89 peptide of guinea pig myelin basic protein (MBP). 
Some animals were injected simultaneously with 107 cloned T cells specific for ovalbumin (OVA). 
Lymphocytes were isolated from the spinal cord and from the peripheral lymphoid organs of these rats 
and the frequencies of MBP-peptide-specific or OVA-specific proliferating cells were estimated by 
limiting dilution analysis at different times after cell transfer. The frequencies of cells specific for 
MBP72-89 or OVA in the spinal cord were highest 5 days after cell transfer (MBP72-89, 1 in 1149; OVA, 
1 in 1116). On day 7, when the rats were recovering, the frequency of cells specific for MBP72-89 in the 
spinal cord fell dramatically to <1 in 105, while that of OVA-specific cells decreased to a much lesser 
extent (1 in 7001). The frequencies of MBP72-89-specific cells in the peripheral lymphoid organs during 
and after recovery were also much lower than those of OVA-specific cells. A similar pattern of down-
regulation of the MBP-peptide-specific, but not the OVA-specific, T cell response was observed in the 
spleen and mesenteric lymph nodes (MLN) of rats 38 days after the active induction of EAE by 
immunization with equal amounts of MBP and OVA in adjuvants. In the passively transferred model, 
cells isolated from the spinal cord and MLN on day 7 did not regain responsiveness to MBP72-89 after 
incubation with high levels of IL-2, indicating that the unresponsiveness was not due to T cell anergy. 
Thus this study demonstrates that there is a specific down-regulation of the MBP72-89-specific T cell 
response during spontaneous recovery from EAE. This conclusion is consistent with our previous 
observation that Vβ8.2+ T cells are selectively eliminated from the CNS by apoptosis during recovery 
from EAE induced by the passive transfer of Vβ8.2+ T cells reactive to this MBP peptide. In contrast to 
autoreactive T cells, the non-autoreactive T cells that accumulate in the CNS during EAE appear to 
recirculate to the peripheral lymphoid organs.       
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Introduction 
Experimental autoimmune encephalomyelitis (EAE) is a T-cell- mediated demyelinating 
disease of the CNS. In Lewis rats it can be actively induced by a single injection of myelin 
basic protein (MBP) and adjuvants (1) or passively induced by the transfer of activated MBP-
specific T cells (2). The autoimmune  attack is followed by spontaneous clinical recovery. 
After recovery from actively induced EAE there is specific tolerance to MBP as shown by 
resistance to reinduction of EAE by further immunization with MBP (1). It has been proposed 
that the down-regulation of EAE is due to various regulatory cells, either macrophages (3), B 
cells (4), suppressor T cells (5,6) or anti-clonotypic cytotoxic CD8+ cells targeting encephali-
togenic T lymphocytes (7,8). Others have proposed that corticosteroids (9) or inhibitory 
cytokines (10) are responsible for the down-regulation of autoreactive T cells during spontan-
eous recovery. 
 
We have observed T cell apoptosis in the CNS of Lewis rats with EAE, and have proposed 
that this contributes to the spontaneous recovery and to the development of tolerance (11,12). 
Schmied et al. (13) have confirmed this observation and have shown that the T cell apoptosis 
is maximal at the time of clinical recovery. Furthermore, using flow cytometric analysis we 
have shown that, during recovery from EAE induced by the passive transfer of MBP-specific 
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Vβ8.2+ cloned T cells, the apoptotic process selectively affects Vβ8.2+ cells (14). We also 
found that the co-transfer of MBP-specific T cells and cloned T cells specific for ovalbumin 
(OVA) resulted in down-regulation of the MBP-specific but not of the OVA-specific 
proliferative response of T cells isolated from the CNS 6 days after passive transfer (14). 
 
In the present study we further investigated the down-regulation of the T cell response 
during recovery from EAE in order to answer the following questions: (i) do non-CNS-
specific activated T cells that have entered the CNS subsequently exit from the CNS, while 
CNS-antigen-specific cells are deleted in the CNS?, (ii) does anergy (functional tolerance) 
contribute to the down-regulation of the MBP-specific T cell response? and (iii) is the pattern 
of down-regulation similar in passively induced EAE and actively induced EAE? We 
compared the frequencies of MBP-peptide-specific and OVA-specific cells in the CNS and in 
the peripheral lymphoid organs of animals during the course of, and after recovery from, 
EAE following the passive transfer of a MBP-peptide-specific T cell clone and an OVA-
specific T cell clone. We also examined the specific T cell frequencies in animals that had 
recovered from EAE induced by the co-injection of MBP and OVA in adjuvants. In all 
experiments we used limiting dilution analysis to detect small subsets of T cells that are 
functionally relevant in mediating EAE. To determine whether T cell anergy could be 
responsible for the decreased MBP-specific T cell responses following recovery from EAE, 
we examined the MBP-specific proliferative responses of the isolated cells after in vitro 
culture with a high concentration of IL-2 which can reverse T cell anergy (15). Our results 
indicate antigen-specific down-regulation, but not T cell anergy, of MBP-reactive T cells, and 
provide further evidence that autoreactive T cells are deleted in the CNS during spontaneous 
recovery from EAE.  
 
Methods  
Animals 
 
Male and female Lewis rats (JC strain) 8-10 weeks old, were obtained from the breeding 
facilities of the University of Queensland. 
 
T cell clones 
T cell clones specific for the 72-89 peptide of guinea pig MBP (sequence: 
PQKSQRSQDENPVVHF) (MBP72-89) (clone EC2) or OVA (Sigma) (clone OVA-T) were 
developed, maintained and characterized as previously described (14). Both T cell clones 
were CD4+, had similar passage numbers and in vitro proliferation characteristics, and were 
stimulated with their specific antigens in the same way before being transferred into normal 
Lewis rats (14). 
 
Induction of EAE 
EAE was passively induced by the i.v injection of 107 cloned T cells specific for MBP72-89, as 
previously described (14). Some rats were also given 107 cloned OVA-specific T cells 
simultaneously. EAE was actively induced in normal Lewis rats by the intradermal 
inoculation of MBP and OVA in adjuvants. MBP was prepared from guinea pig brain as 
described by Deibler et al. (16). MBP or OVA in 0.9% saline was emulsified in an equal 
volume of incomplete Freund’s adjuvant (Commonwealth Serum Laboratories, Melbourne, 
Australia) containing 4 mg/ml of killed Mycobacterium butyricum (Difco). Each rat received 
50 µg MBP in 0.1 ml emulsion in a footpad of one hindfoot, and 50 µg of OVA in 0.1 ml 
emulsion in a footpad of the other hindfoot. 
 
Limiting dilution analysis of antigen-specific cells 
Single cell suspensions from the mesenteric lymph nodes (MLN), spleen and the spinal cords 
of groups of two or three rats were prepared according to the method described previously 
(14). RPMI 1640 supplemented with 216 mg/l L-glutamine (Gibco), 100 IU penicillin, 100 
µg/ml streptomycin (Sigma), 0.1 mM Na-pyruvate (Gibco), non-essential amino acids 
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(Gibco), 36 mg/l L-asparagine (Sigma), 5 × 10-5 M β-mercaptoethanol (Sigma), 5 µg/ml 
Fungizone (Squibb) and 5% heat-inactivated horse serum (Trace Biosciences) was used as 
culture medium. Red blood cells were removed from the spleen cell suspension by a 5 min 
treatment with 0.147 M NH4Cl at 4°C. The precursor frequency of specifically proliferating 
cells was determined by incubating 24 replicates (unless otherwise stated) of gradually 
increasing numbers of responder cells (four to six dilution steps) with 5 × 105 γ-irradiated 
normal rat thymocytes in the presence or absence of antigen (10 µg/ml MBP72-89 or OVA) in 
96-well U-bottom tissue culture trays (Costar). The approximate precursor frequencies were 
determined in preliminary experiments and then dilutions of responder cells were set up around 
the expected frequencies in order to obtain more accurate results. No cultures contained >105 
responder cells per well, as we found elevated levels of background proliferation (proliferation 
in the absence of antigen) at that cell concentration in the case of lymphocytes from rats with 
EAE. When the percentages of negative wells at high cell concentrations were well above the 
37% cutoff level, the frequency was taken to be <1 in 150,000 cells (the limit of sensitivity of 
the assay) (17). Each well was supplemented with 10 U/ml IL-2 in the form of 20 µl MLA 144 
supernatant 24 h after initiating the assay. For the last 8-12 h of the 7 day incubation, 0.5 µCi 
[3H]thymidine was added to each well. The cells were harvested using a Skatron cell harvester 
and assayed for incorporated radio-activity on a LKB 1025 Betaplate counter. Estimates of 
minimal frequencies of the cells specifically proliferating in the presence of MBP72-89 or OVA 
were calculated according to the method of Taswell (18). Wells were scored as positive 
following antigen stimulation when thymidine uptake (c.p.m.) was greater than twice the 
mean background level (dilutions of responder cells incubated with antigen-presenting cells in 
the absence of antigen) (i.e. when the SI was >2). 
 
 
Fig. 1. Frequencies of T cells specific for MBP72-89 or OVA in the spinal cord of rats 3, 5 and 7 days after cell 
transfer. CNS-infiltrating cells were isolated from the spinal cords of rats after the i.v. injection of 107 cloned T     
cells specific for MBP72-89 (EC2) or after the i.v. co-transfer of 107 EC2 cells and 107 cloned OVA-specific T cells 
(OVA-T), as described in Methods. Day 5a refers to animals with neurological signs commencing on day 5; day       
5b refers to animals with neurological signs commencing on day 4. Two animals were used for each combination      
of  time  point and  type of cell transfer.  Between  16 and 24  replicates of gradually decreasing numbers of cells were  
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cultured in the absence of antigen, or in the presence of 10 µg/ml MBP72-89 peptide or 10 µg/ml OVA, and in the 
presence of 5 × 105 irradiated thymocytes as antigen-presenting cells for 7 days. The wells were supplemented 
with 10 U/mI IL-2 24 h after the assays had been initiated. The frequencies of proliferating cells were estimated as 
described in Methods. The coefficient of linear regression was usually >0.9 for all results above the background 
level which is represented by the dotted line (1 in 150,000 cells). 
 
Effect of IL-2 on lymphocytes isolated from the CNS and MLN 
 
Cells isolated from the spinal cord and MLN of animals 7 days after cell transfer were used 
in a standard proliferation assay against MBP72-89 or were preincubated with 100 U/ml mouse 
recombinant IL-2 (Boehringer Mannheim) for 5 days and then tested in a similar 
proliferation assay. Normal syngeneic irradiated thymocytes (105/well) were incubated, in 
the presence or absence of 20 µg/ml MBP72-89, with 2.5 × 104 CNS-infiltrating cells or 5 × 104 
MLN cells in the primary assay and 1.5 × 104 CNS-infiltrating cells or 3 × 104 MLN cells in 
the secondary assay for 3 days, and pulsed with 0.5 µCi [3H]thymidine per well for the last 6 
h of the incubation. The results were expressed as the means of [3H]thymidine uptake 
(c.p.m.) from duplicate cultures. 
 
Results 
 
Frequencies of T cells specific for MBP72-89 or OVA in the spinal cords of rats with 
passively induced EAE 
 
Tail weakness developed 4-5 days after cell transfer and was sometimes followed by hindlimb 
weakness. Clinical recovery usually began on day 7. The frequencies of specifically 
proliferating cells isolated from the spinal cord 3, 5 and 7 days after cell transfer are shown in 
Fig. 1. Co-transfer of MBP-peptide-specific and OVA-specific cells did not influence the 
clinical manifestations of EAE (not shown). On day 3 after co-transfer, and also on day 5 
when it was the first day of weakness (day 5a), the frequency of MBP-peptide-specific T cells 
in the CNS (day 3: 1 in 9001; day 5a: 1 in 1149) was similar to that of OVA-specific T cells 
(day 3: 1 in 5843; day 5a, 1 in 1116). When the clinical manifestations began on day 4, the 
frequency of OVA-specific cells on day 5 (day 5b) was higher (1 in 1480) than that of MBP-
peptide-specific cells (1 in 2783). By day 7 after co-transfer, when most animals begin to 
recover from EAE, the frequency of MBP-peptide-specific cells had fallen to <1 in 105, while 
the frequency of OVA-specific cells remained relatively high (1 in 7001). The results in rats 
injected with EC2 cells alone were similar to those in rats receiving the combination of EC2 
cells and OVA-T cells, with the frequency of MBP-peptide-specific cells in the CNS falling 
dramatically by day 7 (<1 in 150,000). When OVA-specific T cells alone were injected, there 
was some increase in the number of CNS-infiltrating cells 5 days after cell transfer compared 
with that in normal animals, and when cells were plated out 2 × 103 cells per well (no other 
dilutions were done), the frequency of OVA-specific cells was estimated to be ~ 1 in 104. 
 
Frequencies of MBP-peptide-specific and OVA-specific cells in the MLN and spleens 
of rats with EAE 
 
The frequencies of specifically proliferating cells in the peripheral lymphoid organs of 
animals with EAE are shown in Figs 2 and 3. Both MBP-peptide-specific and OVA-specific 
cells were present at relatively high frequencies in the MLN on day 3 (Fig. 2), although when 
OVA-specific cells were transferred alone, the frequency was lower than when they were co-
transferred with MBP-peptide-specific cells. The frequency of MBP-peptide-specific cells 
subsequently decreased to a much lower level than did the frequency of OVA-specific cells, 
reaching background levels by day 5 (MBP-peptide-specific cells transferred alone) or by day 
7 (when co-transferred). OVA-specific cells were still present at relatively high frequencies 5 
and 7 days after passive transfer (1 in 41,000 to 1 in 52,000). On day 10 OVA-specific cells 
were detectable at a low frequency (1 in 110,000), while MBP-peptide-specific cells could not 
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be detected. In the spleen, OVA-specific cells were present at a very low frequency 3 days 
after sole transfer or co-transfer (Fig. 3). On days 5 and 7, OVA-specific cells were present at 
relatively high frequencies in the spleen (1 in 18,058 to 1 in 30,847) regardless of whether the 
OVA-specific T cells had been given alone or in combination with EC2 cells. The frequency 
of OVA-specific cells declined to lower levels by day 10 (1 in 50,554 and 1 in 105,786). In 
contrast to OVA-specific cells, MBP-peptide-specific cells were not detected in the spleens of 
animals with EAE at any of the studied time points. 
 
 
 
Fig. 2. Frequencies of T cells specific for MBP72-89 or OVA in the MLN of rats 3, 5, 7 and 10 days after cell 
transfer. EC2 cells alone, EC2 cells in combination with OVA-T cells, or OVA-T cells alone were i.v. transferred 
into normal Lewis rats and MLN cells were subsequently isolated from the animals as described in Methods. 
Limiting dilution analysis was carried out as described in Methods and in Fig. 1. 
 
Persistence of OVA-specific cells in the peripheral lymphoid organs 
 
The frequencies of specifically proliferating cells isolated from the peripheral lymphoid 
organs were also estimated 26 and 48 days after the passive induction of EAE by the transfer 
of MBP-peptide-specific EC2 cells and the co-injection of OVA-specific T cells (Fig. 4). 
OVA-specific cells were still present at low frequencies in the MLN and at slightly higher 
frequencies in the spleen 48 days after cell transfer MBP-peptide-specific cells were 
undetectable in the MLN and spleen at both time points. 
 
EAE actively induced by immunization with MBP and OVA 
 
To determine whether MBP-peptide-specific and OVA-specific cells are present in animals 
that have recovered from actively induced EAE, we performed frequency analysis of 
specifically proliferating cells in the spleen 38 days after immunization with MBP and OVA. 
MBP-peptide-specific cells were undetectable, while there was a relatively high frequency of 
OVA-specific proliferating cells (1 in 25,020). 
 
International Immunology (1995) 7 (6): 967-973. 
Fig. 3. Frequencies of T cells specific for MBP72-89 or OVA in the spleen of rats 3, 5, 7 and 10 days after cell 
transfer. EC2 cells alone, EC2 cells in combination with OVA-T cells or OVA-T cells alone were i.v. transferred 
into normal Lewis rats and the spleen cells were subsequently isolated from the animals as described in Methods. 
Limiting dilution analysis was carried out as described in Methods and in Fig. 1. 
 
 
 
Fig. 4. Frequencies of T cells specific for MBP72-89 or OVA in the MLN and spleens of rats that had recovered from 
EAE. EC2 and OVA-T cells were i.v. co-transferred, and 26 or 48 days later the MLN and spleen were removed as 
described in Methods. Limiting dilution was carried out as described in Methods and in Fig. 1, with the exception of 
day 48 when only six wells were set up in the absence of antigen. 
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Effect of IL-2 on lymphocytes isolated from the CNS and MLN of rats recovering from 
EAE 
 
To determine whether MBP-peptide-specific cells were present, but not responding to 
antigen, in the CNS infiltrate or MLN of rats recovering from EAE, spinal cord or MLN cells 
were isolated from rats 7 days after transfer of EC2 cells and incubated for 5 days in culture 
media containing 100 U/ml mouse recombinant IL-2. Figure 5 shows the MBP-peptide-
specific proliferative responses of freshly isolated cells and of those preincubated with IL-2. 
The preincubation did not increase the level of the MBP-peptide-specific proliferative 
response above that obtained in the absence of antigen. 
 
 
 
 
 
Fig. 5. Effect, on MBP72-89-specific proliferation, of in vitro IL-2 pretreatment of lymphocytes isolated from the 
spinal cord and MLN of rats 7 days after the i.v. administration of 107 EC2 cells. A standard 3 day proliferation assay 
in the presence of 105 irradiated thymocytes per well was carried out either on freshly isolated cells (no preincubation 
with IL-2) or on cells that had been preincubated with 100 U/ml mouse recombinant IL-2 for 5 days after isolation 
from the spinal cord or MLN. The mean + SD of [3H]thymidine uptake (c.p.m.) obtained from duplicate cultures in 
the absence of antigen or in the presence of 20µg/ml MBP72-89 are shown. 
 
Discussion 
This study indicates that there is an antigen-specific down-regulation of the T cell response to 
MBP72-89 in the CNS during spontaneous clinical recovery from EAE induced by the passive 
transfer of activated T cells specific for MBP72-89. Furthermore, after recovery there is no 
detectable T cell response to this peptide in the peripheral lymphoid organs. The 
responsiveness to MBP72-89 was not restored by incubating CNS-infiltrating cells and MLN 
cells with IL-2. This indicates that deletion and not anergy is responsible for the loss of 
responsiveness. We have confirmed the findings of Ludowyk et al. (19) that activated T cells 
specific for a non-CNS-antigen (OVA) accumulate in the CNS in EAE to a greater degree than 
in the normal CNS. Our results also indicate that, in contrast to autoreactive T cells, the non-
autoreactive T cells that accumulate in the CNS during EAE recirculate to the peripheral 
lymphoid organs. T cell responsiveness to OVA persisted in the peripheral lymphoid organs 
for at least 48 days after the co-transfer of MBP72-89-specific T cells and OVA-specific T 
cells. Similarly, in actively induced EAE, T cell responsiveness to OVA but not to 
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MBP72-89 could be detected in the spleen 38 days after immunization with OVA and 
MBP72-89. 
 
The present finding of antigen-specific down-regulation of T cells reactive to MBP72-
89 is consistent with our previous observation that Vβ8.2+ T cells are selectively 
eliminated from the CNS by apoptosis during recovery from EAE induced by the 
passive transfer of Vβ8.2+ T cells reactive to MBP72-89 (14). Although this mechanism 
appears to be highly effective in eliminating the transferred encephalitogenic T cells 
from the CNS and peripheral lymphoid organs, it would not be expected to result in the 
elimination of all of the recipient’s MBP72-89-reactive T cells from the peripheral 
lymphoid organs as these T cells would not have been activated and therefore not have 
entered the CNS. A frequency of MBP72-89-reactive T cells similar to that of the 
background response in the normal rat would not have been detected in our assays. The 
present study suggests that the decline in the MBP-peptidespecific T cell response is not 
mediated by an anti-clonotypic mechanism, which has been demonstrated in the spleens 
of animals that have recovered from EAE (7,8), as such a mechanism would be 
expected similarly to affect OVA-specific cells. Furthermore, the selective decline in 
the frequency of MBP72-89-specific cells is not likely to be solely due to the elevated 
levels of glucocorticoids which are found in EAE (9), as glucocorticoids would be 
expected to have the same inhibitory effect on all T cells. However, it is possible that 
glucocorticoids may enhance activation-induced apoptosis of T cells specific for MBP72-
89 (see below) by inhibiting IL-2 production. 
 
Re-engagement of the T cell receptor of MBP-peptide-specific cells and not that of 
OVA-specific cells in vivo could account for the selective loss of MBP-reactive cells in 
EAE. After entering the CNS, activated MBP-specific T cells may again encounter 
antigen on the surface of bone-marrow-derived cells, such as macrophages or microglia 
(20-22) or possibly on parenchymal cells such as astrocytes or endothelial cells (22-24). 
If MBP-specific cells encounter antigen on the surface of non-professional antigen-
presenting cells such as astrocytes or possibly microglia which are unable to deliver the 
second signal necessary for proliferation, this suboptimal stimulation might lead to 
activation-induced apoptotic T cell deletion as has been observed in other models of T 
cell activation (reviewed in 25). During the course of EAE there is increased class II 
MHC antigen expression on microglia (26-28) which may increase antigen presentation 
by these cells and lead to activation-induced T cell apoptosis. 
 
In conclusion, our findings from this study together with those from our previous 
study (14) indicate that antigen-specific apoptotic deletion of autoreactive T cells in the 
target organ has an important role in the down-regulation of autoimmune disease. We 
hypothesize that failure of this normal protective mechanism may predispose to the 
development and perpetuation of chronic autoimmune disease. As apoptosis is an active 
process that can be modulated, it may be feasible to increase the sensitivity of 
autoreactive T cells to apoptosis and thus reduce the severity of an autoimmune attack. 
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